[Events and errors in radiation oncology: Conciliating perspectives to support care].

Survenue d’un évènement ou d’une erreur en oncologie radiothérapie : concilier les perspectives pour préserver le soin.
Erreur Errors Ethics Events Oncologie radiothérapie Radiation oncology Éthique Évènement

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272

Informations de publication

Date de publication:
04 Oct 2024
Historique:
received: 26 07 2024
accepted: 29 07 2024
medline: 6 10 2024
pubmed: 6 10 2024
entrez: 5 10 2024
Statut: aheadofprint

Résumé

The term "event" covers a wide range of concrete situations in radiation oncology, from particularly intense radiation-related side effects to the possibility of technical or human error. Although quality procedures are an integral part of radiotherapy oncology department operations ensuring the analysis and prevention of such events, their occurrence during radiation treatment still has a significant impact on patients and their experience of the treatment process, as well as on health professionals. These practical, emotional and symbolic impacts are all the greater when the event occurs in the aftermath of an error. The ethical approach therefore comprises three essential stages: recognizing the event as such, informing those involved of the event and, finally, creating conditions for the continuation of care. Each of these stages is marked by specific issues and questions, requiring a complex ethical approach that constantly involves reconciling the possible divergent perceptions of patients and health professionals. The occurrence of an event can also lead to a genuine crisis of confidence with multiple dimensions, which health professionals will also have to face and to support. Finally, the occurrence of an event calls into question not only our responsibility towards patients, but also our ideal of control. We need to criticize our culture of performance, rethink our approach to events and errors, and see them also as opportunities for positive change.

Identifiants

pubmed: 39368919
pii: S1278-3218(24)00144-6
doi: 10.1016/j.canrad.2024.07.017
pii:
doi:

Types de publication

English Abstract Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Thibaud Haaser (T)

Service d'oncologie radiothérapie, hôpital Haut-Lévêque, centre hospitalier universitaire de Bordeaux, Pessac, France; Centre éthique et recherche en santé de Bordeaux, centre hospitalier universitaire de Bordeaux, Bordeaux, France; EA 4574 sciences, philosophie, humanités, universités de Bordeaux et Bordeaux-Montaigne, Pessac, France. Electronic address: thibaud.haaser@chu-bordeaux.fr.

Yannis Constantinides (Y)

Espace éthique Île-de-France, Paris université Sorbonne Nouvelle, Paris 4, Paris, France.

David Osman (D)

Service de médecine intensive-réanimation, hôpital de Bicêtre, université Paris-Saclay, AP-HP, DMU Correve, Le Kremlin-Bicêtre, France.

Lucien Lahmi (L)

Service d'oncologie radiothérapie, institut Curie, Paris, France.

Catherine Durdux (C)

Service d'oncologie radiothérapie, hôpital européen Georges-Pompidou, Paris, France.

Vincent Bourbonne (V)

Service d'oncologie radiothérapie, centre hospitalier universitaire de Brest, Brest, France.

Véronique Cheval (V)

Service universitaire d'oncologie radiothérapie, centre Oscar-Lambret, Lille, France.

Renaud de Crevoisier (R)

Service d'oncologie radiothérapie, centre Eugène-Marquis, Rennes, France.

Catherine Dejean (C)

Service d'oncologie radiothérapie, unité de physique médicale, centre Antoine-Lacassagne, Nice, France.

Angélique Ducteil (A)

Centre d'oncologie et de radiothérapie du Pays-Basque, Bayonne, France.

Alexandre Escande (A)

Service universitaire d'oncologie radiothérapie, centre Oscar-Lambret, Lille, France; Laboratoire CRIStAL, UMR9189, faculté de médecine Henri-Warembourg, université de Lille, Lille, France.

Cédric Gesbert (C)

Direction de la qualité, des services aux patients et des parcours, centre hospitalier de Versailles, Versailles, France.

Youssef Ghannam (Y)

UMR_S 938, service d'oncologie radiothérapie, hôpital Tenon, centre de recherche Saint-Antoine, institut universitaire de cancérologie, Sorbonne université, AP-HP, Paris, France.

Claire Lemanski (C)

Service d'oncologie radiothérapie, institut du cancer de Montpellier, Montpellier, France.

Sébastien Thureau (S)

Service d'oncologie radiotherapie, Quantis Litis EA 4108, centre Henri-Becquerel, Rouen, France.

Jean-Léon Lagrange (JL)

Université Paris-Est Créteil Val-de-Marne, Paris, France.

Florence Huguet (F)

UMR_S 938, service d'oncologie radiothérapie, hôpital Tenon, centre de recherche Saint-Antoine, institut universitaire de cancérologie, Sorbonne université, AP-HP, Paris, France.

Classifications MeSH